News Healios K.K.

Equities

4593

JP3835100003

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-25 am EDT			5-day change	1st Jan Change
148 ^JPY	-2.63%		+2.78%	-10.30%

Apr. 10	Healios Partners with AND Medical Group; Set to Receive Upfront Payment of 60 Million Yen	MT
Apr. 09	Healios K.K. Enters into Joint Research Agreement with AND Medical Group	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Healios Partners with AND Medical Group; Set to Receive Upfront Payment of 60 Million Yen	Apr. 09	MT
Healios K.K. Enters into Joint Research Agreement with AND Medical Group	Apr. 08	CI
Healios Concludes Purchase of Athersys Assets, Becoming Sole Owner of MultiStem IP	Apr. 04	MT
Healios K.K. completed the acquisition of Substantially all assets of Abt Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC .	Apr. 02	CI
Japanese Shares Hit Fresh 52-Week Peak Ahead of Inflation Data	Feb. 26	MT
Healios Proposes Reduction of Capital Stock, Reserves, Surplus Appropriation	Feb. 25	MT
Jefferies Adjusts Healios K.K.’s Price Target at 140 Yen From 170 Yen, Keeps at Hold	Feb. 20	MT
Healios K.K. announced that it has received ¥2.2600715 billion in funding	Feb. 08	CI
Healios K.K. and ProcellCure Inc. Announce Start of ARDS Clinical Trial in Japan	Feb. 01	CI
Healios K.K. announced that it expects to receive ¥2.2600715 billion in funding	Jan. 24	CI
Healios and ProcellCure Initiate Clinical Trial for ARDS Treatment	Jan. 18	MT
Japanese Shares Finish Lower After Key Economic Data	Jan. 18	MT
Healios K.K. and Its Wholly Owned Subsidiary ProcellCure Inc. Announce Submission of ARDS Clinical Trial Notification in Japan	Jan. 17	CI
Healios' Ischemic Stroke Trial Data Published in JAMA Neurology Journal	Jan. 17	MT
Healios Secures LOI on Joint Research with AND	Jan. 17	MT
Healios K.K. AND Medical Group Enter into A Letter of Intent for A Basic Agreement for Joint Research	Jan. 15	CI
Healios Steps In as Primary Bidder and Lender for Athersys’s Asset Sale Amidst Bankruptcy	Jan. 10	MT
Healios K.K. entered into an asset purchase agreement to acquire Substantially all assets of ABT Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC for $2.8 million.	Jan. 04	CI
Healios, Nobelpharma in Talks for Stem Cell Therapy Alliance for ARDS	Dec. 28	MT
Healios Invests in Arktus Therapeutics at Undisclosed Amount	Dec. 26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Healios K.K.

Equities

4593

JP3835100003

Summary

Filters